Magnetic resonance imaging does not improve the prediction of misclassification of prostate cancer patients eligible for active surveillance when the most stringent selection criteria are based on the saturation biopsy scheme

scientific article published on 22 December 2010

Magnetic resonance imaging does not improve the prediction of misclassification of prostate cancer patients eligible for active surveillance when the most stringent selection criteria are based on the saturation biopsy scheme is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1464-410X.2010.09974.X
P698PubMed publication ID21176083

P2093author name stringYves Allory
Alexandre de la Taille
Laurent Salomon
Guillaume Ploussard
Evanguelos Xylinas
Xavier Durand
Claude-Clément Abbou
Idir Ouzaïd
Mohamed Bouanane
P433issue4
P921main subjectprostate cancerQ181257
P304page(s)513-517
P577publication date2010-12-22
P1433published inBJU InternationalQ4835773
P1476titleMagnetic resonance imaging does not improve the prediction of misclassification of prostate cancer patients eligible for active surveillance when the most stringent selection criteria are based on the saturation biopsy scheme
P478volume108

Reverse relations

cites work (P2860)
Q42907440Abnormal findings on multiparametric prostate magnetic resonance imaging predict subsequent biopsy upgrade in patients with low risk prostate cancer managed with active surveillance
Q43428500Can high-spatial resolution T2-weighted endorectal MRI rule out clinically significant prostate cancer?
Q90989090MRI in active surveillance: a critical review
Q41686096Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer
Q86093329Magnetic resonance-invisible versus magnetic resonance-visible prostate cancer in active surveillance: a preliminary report on disease outcomes
Q34459820Multiparametric magnetic resonance imaging enhances detection of significant tumor in patients on active surveillance for prostate cancer
Q37377731Multiparametric magnetic resonance imaging for pre-treatment local staging of prostate cancer: A Cancer Care Ontario clinical practice guideline
Q36387925Nonvisible tumors on multiparametric magnetic resonance imaging does not predict low-risk prostate cancer.
Q47411446Pathologic findings in radical prostatectomy specimens from patients eligible for active surveillance with highly selective criteria: a multicenter study
Q36346204Performance characteristics of MR imaging in the evaluation of clinically low-risk prostate cancer: a prospective study
Q40458086Predicting Pathological Features at Radical Prostatectomy in Patients with Prostate Cancer Eligible for Active Surveillance by Multiparametric Magnetic Resonance Imaging.
Q37037038Prostate MRI: a national survey of Urologist's attitudes and perceptions
Q26849794The role of magnetic resonance imaging in the diagnosis and management of prostate cancer
Q38795731Use of mpMRI in active surveillance for localized prostate cancer

Search more.